PI Industries Ltd Share Price

A strong franchise. A clean balance sheet.

📊 **PI Industries Q1 FY27: Profit Under Pressure Despite Strong Core Position**

🔬 **PI Industries** reported a weak set of Q1 FY27 numbers, with revenue and profitability declining sharply year-on-year. 📌 **Key Highlights:** • Consolidated Revenue: ₹1,702 Cr, down **10.4% YoY** • Consolidated PAT: ₹244 Cr, down **38.9% YoY** • EPS: ₹16.10 vs ₹26.37 YoY • Agrochemicals Revenue: ₹1,649 Cr, down **9.8% YoY** • Agrochemicals PBT: ₹384 Cr, down **32.2% YoY** • Pharma Revenue: ₹54 Cr, down **25% YoY** • Pharma remained loss-making with PBT loss of ₹82 Cr. 🔎 **Investor Takeaway** The core **Agrochemicals business continues to drive PI Industries**, but the sharp decline in segment profitability is the key concern. Pharma also remains under pressure. The absence of a fresh exceptional loss in Q1 provides some comfort, but the underlying earnings performance remains weak. Investors should closely track demand recovery, margins and the performance of the Pharma business in the coming quarters. 📉 **Verdict:** Q1 FY27 numbers are **weak**, with profitability declining much faster than revenue. 📢 Follow for more **results analysis, corporate actions & market insights.** ⚠️ **Disclaimer:** This post is for educational and informational purposes only and should not be considered investment advice. Please do your own research before making any investment decisions.

PI Industries Limited Latest Updates

Chemicals Sector

PI Industries Specialty chemicals continue benefiting from global supply chain diversification and increasing outsourcing by multinational companies.

India’s Chemical Reset: The Next Manufacturing Opportunity ?

For years, India's chemical industry has lived with one major weakness—we consume far more chemicals than we produce. India imported nearly $75 billion worth of chemicals while exporting only $44 billion, leaving a trade deficit of $31 billion. A large share of these imports comes from China, especially critical raw materials used in pharmaceuticals, agrochemicals and specialty chemicals. This dependence has become both an economic and strategic concern. To address this, the Government has steadily expanded Quality Control Orders, making BIS certification mandatory for an increasing number of chemical products. The objective is not only to improve product quality but also to encourage domestic manufacturing, reduce low-quality imports and strengthen India's position in global supply chains. The opportunity becomes even bigger when combined with the China+1 strategy. Global companies are increasingly diversifying manufacturing away from China, and India is emerging as an attractive alternative because of its engineering talent, regulatory capabilities and expanding industrial ecosystem. However, the transition will not be smooth. While large integrated companies can absorb compliance costs, many MSMEs may initially face higher expenses and operational challenges before the long-term benefits materialise. • PI Industries